Peter Bette
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
-
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Clostridium difficile and Clostridium perfringens research 3
-
- Toxin Mechanisms and Immunotoxins 1
- Co-authors
- Ernst Habermann (3 shared papers)Michel Robert Popoff (1 shared paper)C. von Eichel-Streiber (1 shared paper)A. Oksche (1 shared paper)Peter Presek (1 shared paper)Christoph W. Reuter (1 shared paper)Duygu Fındık (1 shared paper)Norbert Suttorp (1 shared paper)
- Journals
- Toxicon (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)Infection and Immunity (1 paper)Pediatric Research (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- GermanyNetherlandsFrance
In The Last Decade
Peter Bette
8 papers receiving 529 citations
Peers
Comparison fields: 5 of 53
- Oncology 256
- Infectious Diseases 71
- Radiology, Nuclear Medicine and Imaging 83
- Immunology 56
- Molecular Biology 119
Countries citing papers authored by Peter Bette
This map shows the geographic impact of Peter Bette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bette more than expected).
Fields of papers citing papers by Peter Bette
This network shows the impact of papers produced by Peter Bette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bette. The network helps show where Peter Bette may publish in the future.
Co-authors
The 24 scholars most cited alongside Peter Bette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. | 2003 | 397 |
| 2 | 1991 | 57 | |
| 3 | 1988 | 28 | |
| 4 | 1989 | 28 | |
| 5 | Immortalization of rat hepatocytes by fusion with hepatoma cells. I. Cloning of a hepatocytoma cell line with bile canaliculi. | 1994 | 16 |
| 6 | 2000 | 14 | |
| 7 | 1993 | 6 | |
| 8 | 1990 | 3 |
About Peter Bette
Peter Bette is a scholar working on Infectious Diseases, Immunology, Immunology and Allergy, Pharmaceutical Science and Hepatology, having authored 8 papers that have together received 549 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (3 papers), Intravenous Infusion Technology and Safety (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Liver physiology and pathology (1 paper), Drug Solubulity and Delivery Systems (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Reproductive Biology and Fertility (1 paper). The work is most often cited by research in Oncology (256 citations), Infectious Diseases (71 citations), Radiology, Nuclear Medicine and Imaging (83 citations), Immunology (56 citations) and Molecular Biology (119 citations). Peter Bette has collaborated with scholars based in Germany, Netherlands and France. Frequent co-authors include Ernst Habermann, Michel Robert Popoff, C. von Eichel-Streiber, A. Oksche, Peter Presek, Christoph W. Reuter, Duygu Fındık, Norbert Suttorp, J. Frevert and Linda D Voss. Their work appears in journals such as Toxicon, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Infection and Immunity, Pediatric Research and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.